{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:51:26Z","timestamp":1790286686393,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T00:00:00Z","timestamp":1692316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T00:00:00Z","timestamp":1692316800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Scientific Research Fund of Necmettin Erbakan University","award":["201218014"],"award-info":[{"award-number":["201218014"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-023-03489-2","type":"journal-article","created":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T19:01:33Z","timestamp":1692385293000},"page":"638-645","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Expression of endocan and vascular endothelial growth factor and their correlation with histopathological prognostic parameters in pheochromocytoma"],"prefix":"10.1007","volume":"82","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6473-4164","authenticated-orcid":false,"given":"Muhammet","family":"Kocaba\u015f","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3241-4104","authenticated-orcid":false,"given":"Mustafa","family":"Can","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7990-8350","authenticated-orcid":false,"given":"Melia","family":"Karak\u00f6se","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8559-2476","authenticated-orcid":false,"given":"Hac\u0131 Hasan","family":"Esen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9908-7449","authenticated-orcid":false,"given":"Mustafa","family":"Kulaksizo\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7629-9625","authenticated-orcid":false,"given":"Feridun","family":"Karakurt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,18]]},"reference":[{"issue":"34","key":"3489_CR1","doi-asserted-by":"publisher","first-page":"8812","DOI":"10.1200\/JCO.2005.03.1484","volume":"23","author":"L Amar","year":"2005","unstructured":"L. Amar, J. Bertherat, E. Baudin et al. Genetic testing in pheochromocytoma or functional paraganglioma. J. Clin. Oncol. 23(34), 8812\u20138818 (2005)","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"3489_CR2","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1210\/jc.2014-1498","volume":"99","author":"JW Lenders","year":"2014","unstructured":"J.W. Lenders, Q.Y. Duh, G. Eisenhofer et al. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 99(6), 1915\u20131942 (2014)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"3489_CR3","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1055\/s-0031-1299707","volume":"44","author":"PF Plouin","year":"2012","unstructured":"P.F. Plouin, P. Fitzgerald, T. Rich, et al. Metastatic pheochromocytoma and paraganglioma: focus on therapeutics. Horm. Metab. Res. 44(5), 390\u2013399 (2012)","journal-title":"Horm. Metab. Res."},{"issue":"5","key":"3489_CR4","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1097\/00000478-200205000-00002","volume":"26","author":"LD Thompson","year":"2002","unstructured":"L.D. Thompson, Pheochromocytoma of the Adrenal gland Scaled Score (PASS) to separate benign from malignant neoplasms: a clinicopathologic and immunophenotypic study of 100 cases. Am. J. Surg. Pathol. 26(5), 551\u2013566 (2002)","journal-title":"Am. J. Surg. Pathol."},{"issue":"6","key":"3489_CR5","doi-asserted-by":"publisher","first-page":"579","DOI":"10.4103\/0253-7613.144891","volume":"46","author":"A Kali","year":"2014","unstructured":"A. Kali, K.S. Shetty, Endocan: a novel circulating proteoglycan. Indian J. Pharmacol. 46(6), 579\u2013583 (2014)","journal-title":"Indian J. Pharmacol."},{"key":"3489_CR6","doi-asserted-by":"publisher","first-page":"705027","DOI":"10.1155\/2013\/705027","volume":"2013","author":"M Delehedde","year":"2013","unstructured":"M. Delehedde, L. Devenyns, C.A. Maurage, R.R. Viv\u00e8s, Endocan in cancers: a lesson from a circulating dermatan sulfate proteoglycan. Int. J. Cell Biol. 2013, 705027 (2013)","journal-title":"Int. J. Cell Biol."},{"key":"3489_CR7","doi-asserted-by":"publisher","first-page":"6297","DOI":"10.2147\/OTT.S110295","volume":"9","author":"X Huang","year":"2016","unstructured":"X. Huang, C. Chen, X. Wang et al. Prognostic value of endocan expression in cancers: evidence from meta-analysis. Onco Targets Ther. 9, 6297\u20136304 (2016)","journal-title":"Onco Targets Ther."},{"issue":"6","key":"3489_CR8","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1097\/NEN.0b013e3181a52a7f","volume":"68","author":"CA Maurage","year":"2009","unstructured":"C.A. Maurage, E. Adam, J.F. Mineo et al. Endocan expression and localization in human glioblastomas. J. Neuropathol. Exp. Neurol. 68(6), 633\u2013641 (2009)","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"2","key":"3489_CR9","doi-asserted-by":"publisher","first-page":"5519","DOI":"10.4238\/2015.May.25.3","volume":"14","author":"H Jiang","year":"2015","unstructured":"H. Jiang, X.G. Fu, Y.T. Chen, Serum level of endothelial cell-specific molecule-1 and prognosis of colorectal cancer. Genet. Mol. Res. 14(2), 5519\u20135526 (2015)","journal-title":"Genet. Mol. Res."},{"issue":"5","key":"3489_CR10","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.3892\/or.2012.2012","volume":"28","author":"JH Kim","year":"2012","unstructured":"J.H. Kim, M.Y. Park, C.N. Kim et al. Expression of endothelial cell-specific molecule-1 regulated by hypoxia inducible factor-1alpha in human colon carcinoma: impact of ESM-1 on prognosis and its correlation with clinicopathological features. Oncol. Rep. 28(5), 1701\u20131708 (2012)","journal-title":"Oncol. Rep."},{"issue":"3","key":"3489_CR11","doi-asserted-by":"publisher","first-page":"221","DOI":"10.7150\/jca.7691","volume":"5","author":"K Ozaki","year":"2014","unstructured":"K. Ozaki, N. Toshikuni, J. George et al. Serum endocan as a novel prognostic biomarker in patients with hepatocellular carcinoma. J. Cancer 5(3), 221\u2013230 (2014)","journal-title":"J. Cancer"},{"issue":"2","key":"3489_CR12","first-page":"731","volume":"31","author":"K Hata","year":"2011","unstructured":"K. Hata, Y. Watanabe, H. Nakai, T. Hata, H. Hoshiai, Expression of the vascular endothelial growth factor (VEGF) gene in epithelial ovarian cancer: an approach to anti-VEGF therapy. Anticancer Res. 31(2), 731\u2013737 (2011)","journal-title":"Anticancer Res."},{"issue":"1","key":"3489_CR13","first-page":"37","volume":"49","author":"M Raica","year":"2008","unstructured":"M. Raica, L. Mogoant\u0103, A.M. C\u00eempean et al. Immunohistochemical expression of vascular endothelial growth factor (VEGF) in intestinal type gastric carcinoma. Rom. J. Morphol. Embryol. 49(1), 37\u201342 (2008)","journal-title":"Rom. J. Morphol. Embryol."},{"key":"3489_CR14","doi-asserted-by":"publisher","first-page":"746749","DOI":"10.1155\/2013\/746749","volume":"2013","author":"N Srabovic","year":"2013","unstructured":"N. Srabovic, Z. Mujagic, J. Mujanovic-Mustedanagic et al. Vascular endothelial growth factor receptor-1 expression in breast cancer and its correlation to vascular endothelial growth factor a. Int. J. Breast Cancer 2013, 746749 (2013)","journal-title":"Int. J. Breast Cancer"},{"issue":"3","key":"3489_CR15","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/j.1464-410X.2004.04605.x","volume":"93","author":"J Jacobsen","year":"2004","unstructured":"J. Jacobsen, K. Grankvist, T. Rasmuson, A. Bergh, G. Landberg, B. Ljungberg, Expression of vascular endothelial growth factor protein in human renal cell carcinoma. BJU Int. 93(3), 297\u2013302 (2004)","journal-title":"BJU Int."},{"issue":"6801","key":"3489_CR16","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/35025220","volume":"407","author":"P Carmeliet","year":"2000","unstructured":"P. Carmeliet, R.K. Jain, Angiogenesis in cancer and other diseases. Nature 407(6801), 249\u2013257 (2000)","journal-title":"Nature"},{"issue":"4","key":"3489_CR17","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/S0002-9440(10)64400-8","volume":"161","author":"J Favier","year":"2002","unstructured":"J. Favier, P.F. Plouin, P. Corvol, J.M. Gasc, Angiogenesis and vascular architecture in pheochromocytomas: distinctive traits in malignant tumors. Am. J. Pathol. 161(4), 1235\u20131246 (2002)","journal-title":"Am. J. Pathol."},{"issue":"1","key":"3489_CR18","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1097\/BCR.0b013e3181c7ed82","volume":"31","author":"AA Ucuzian","year":"2010","unstructured":"A.A. Ucuzian, A.A. Gassman, A.T. East, H.P. Greisler, Molecular mediators of angiogenesis. J. Burn Care Res. 31(1), 158\u2013175 (2010)","journal-title":"J. Burn Care Res."},{"issue":"8","key":"3489_CR19","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/S0009-9260(97)80252-8","volume":"52","author":"JC Varghese","year":"1997","unstructured":"J.C. Varghese, P.F. Hahn, N. Papanicolaou, W.W. Mayo-Smith, J.A. Gaa, M.J. Lee, MR differentiation of phaeochromocytoma from other adrenal lesions based on qualitative analysis of T2 relaxation times. Clin. Radiol. 52(8), 603\u2013606 (1997)","journal-title":"Clin. Radiol."},{"key":"3489_CR20","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.jss.2017.04.011","volume":"215","author":"PP Parikh","year":"2017","unstructured":"P.P. Parikh, G.A. Rubio, J.C. Farra, J.I. Lew, Nationwide review of hormonally active adrenal tumors highlights high morbidity in pheochromocytoma. J. Surg. Res. 215, 204\u2013210 (2017)","journal-title":"J. Surg. Res."},{"issue":"6","key":"3489_CR21","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/S0039-6060(96)80037-7","volume":"120","author":"Q Liu","year":"1996","unstructured":"Q. Liu, G. Djuricin, E.D. Staren et al. Tumor angiogenesis in pheochromocytomas and paragangliomas. Surgery 120(6), 938\u2013943 (1996)","journal-title":"Surgery"},{"issue":"4","key":"3489_CR22","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1046\/j.1464-410x.2001.00102.x","volume":"87","author":"H Ohji","year":"2001","unstructured":"H. Ohji, I. Sasagawa, O. Iciyanagi, Y. Suzuki, T. Nakada, Tumour angiogenesis and Ki-67 expression in phaeochromocytoma. BJU Int. 87(4), 381\u2013385 (2001)","journal-title":"BJU Int."},{"issue":"4","key":"3489_CR23","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1034\/j.1600-0463.2003.1110402.x","volume":"111","author":"K Salmenkivi","year":"2003","unstructured":"K. Salmenkivi, P. Heikkil\u00e4, J. Liu, C. Haglund, J. Arola, VEGF in 105 pheochromocytomas: enhanced expression correlates with malignant outcome. APMIS 111(4), 458\u2013464 (2003)","journal-title":"APMIS"},{"issue":"6","key":"3489_CR24","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1067\/msy.2002.128613","volume":"132","author":"A Zielke","year":"2002","unstructured":"A. Zielke, M. Middeke, S. Hoffmann et al. VEGF-mediated angiogenesis of human pheochromocytomas is associated to malignancy and inhibited by anti-VEGF antibodies in experimental tumors. Surgery 132(6), 1056\u20131063 (2002)","journal-title":"Surgery"},{"issue":"15","key":"3489_CR25","doi-asserted-by":"publisher","first-page":"4575","DOI":"10.1158\/1078-0432.CCR-06-0185","volume":"12","author":"BD Grigoriu","year":"2006","unstructured":"B.D. Grigoriu, F. Depontieu, A. Scherpereel et al. Endocan expression and relationship with survival in human non-small cell lung cancer. Clin. Cancer Res. 12(15), 4575\u20134582 (2006)","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"3489_CR26","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/j.1365-2559.2009.03458.x","volume":"56","author":"X Leroy","year":"2010","unstructured":"X. Leroy, S. Aubert, L. Zini et al. Vascular endocan (ESM-1) is markedly overexpressed in clear cell renal cell carcinoma. Histopathology 56(2), 180\u2013187 (2010)","journal-title":"Histopathology"},{"issue":"2","key":"3489_CR27","doi-asserted-by":"publisher","first-page":"5519","DOI":"10.4238\/2015.May.25.3","volume":"14","author":"H Jiang","year":"2015","unstructured":"H. Jiang, X.G. Fu, Y.T. Chen, Serum level of endothelial cell-specific molecule-1 and prognosis of colorectal cancer. Genet. Mol. Res. 14(2), 5519\u20135526 (2015)","journal-title":"Genet. Mol. Res."},{"issue":"9","key":"3489_CR28","doi-asserted-by":"publisher","first-page":"2726","DOI":"10.1210\/clinem\/dgab202","volume":"106","author":"S Moog","year":"2021","unstructured":"S. Moog, F. Castinetti, C. DoCao et al. Recurrence-free survival analysis in locally advanced pheochromocytoma: first appraisal. J. Clin. Endocrinol. Metab. 106(9), 2726\u20132737 (2021)","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-023-03489-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-023-03489-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-023-03489-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T05:13:46Z","timestamp":1698729226000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-023-03489-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,18]]},"references-count":28,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3489"],"URL":"https:\/\/doi.org\/10.1007\/s12020-023-03489-2","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,18]]},"assertion":[{"value":"9 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The Ethics Committee of the Necmettin Erbakan University (NEU) Meram Medical Faculty approved the study (decision no: 2020\/2504 and date: 22.05.2020).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}